00:21:56 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Aurora Cannabis Inc
Symbol ACB
Shares Issued 998,596,023
Close 2019-02-22 C$ 9.14
Market Cap C$ 9,127,167,650
Recent Sedar Documents

Aurora Cannabis receives pot licence for Sky, Bradford

2019-02-25 07:11 ET - News Release

Mr. Terry Booth reports

AURORA CANNABIS RECEIVES HEALTH CANADA LICENSING OF AURORA SKY AND MEDRELEAF BRADFORD

Both Aurora Cannabis Inc.'s Aurora Sky and MedReleaf Bradford facilities are now fully licensed by Health Canada for the production and sale of cannabis and cannabis derivative products.

"The rapid scale-up of our production capacity -- with our Sky and Bradford facilities specifically adding over 128,000 kilograms per year in capacity -- is resulting in significant increases in product availability across our domestic medical and consumer, as well as our international market segments, over the coming months," said Terry Booth, chief executive officer of Aurora. "Current production at Aurora Sky, with recent harvests exceeding target yields, validates our production philosophy and our investment in high-tech, highly automated facilities. MedReleaf Bradford employs best practices identified during the integration of the Aurora and MedReleaf organizations, and is consistently delivering exceptional yields and high-quality product that has resonated well in both the medical and consumer markets."

Aurora Sky

Located at the Edmonton International Airport in Alberta, Aurora Sky is the company's first Sky Class facility. Aurora Sky is designed to deliver high-quality, consistent and highly cost-efficient cannabis cultivation. At 800,000 square feet, the facility delivers massive scale, incorporates state-of-the-art technology and leverages a high degree of automation to deliver target production costs of well below $1 per gram. With the entire facility's cultivation space now licensed by Health Canada, the company anticipates the facility to be fully planted in March, 2019, with the full impact of product available for sale to be realized by the end of June, 2019.

MedReleaf Bradford

Located in Ontario, MedReleaf Bradford is a 210,000-square-foot high-tech production facility built to European Union good manufacturing practice specifications which features 17 independently climate-controlled grow rooms. Designed for large-scale, hang-dried, hand-manicured production, 13 of the flower rooms are currently in production to service the consumer and medical markets. With the facility's cultivation space now completely licensed, Aurora anticipates the facility to be fully planted by early April, 2019, reflecting a production capacity of 28,000 kg of high-quality cannabis per annum.

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alta., Canada, with financed capacity in excess of 500,000 kg per annum and sales and operations in 23 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, and wholesale and retail distribution.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.